Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients

Martín-Carbonero, Luz; Domínguez-Domínguez, Lourdes; Bailón, Lucía; Torres, Rafael; Rubio, Rafael; Ron, Raquel; Moreno, Francisco; Rico, Mikel; Jimenez-Nacher, Inmaculada; González-García, Juan; Pulido, Federico; Montes, María Luisa.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 37(6): 367-372, jun.-jul. 2019. graf, tab
Artículo en Inglés | IBECS (España) | ID: ibc-189342

Documentos relacionados

  1. Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study.
  2. Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
  3. Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
  4. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4<sup>+</sup> T cell reservoir.
  5. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
  6. Significance of initiating antiretroviral therapy in the early stage of HIV infection.
  7. Changes in health and sleep quality after anti-retroviral treatment modification in Japanese people living with HIV.
  8. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.
  9. Duration of antiretroviral therapy impacts the degree of residual SIV infection in the gut in long-term non-progressing Chinese rhesus macaques.
  10. Overcoming Barriers to HIV Care: Findings from a Peer-Delivered, Community-Based, Linkage Case Management Program (CommLink), Eswatini, 2015-2018.